Publications by authors named "Anton A Tikhonov"
Article Synopsis
- Azoximer bromide (AZB) was studied for its safety and efficacy in treating hospitalized COVID-19 patients, given its established benefits for upper respiratory infections in Russia.
- In the study, 81 patients received AZB in combination with standard care, showing clinical improvement with no deaths reported during hospitalization, but one patient required ongoing respiratory support after 28 days.
- Although AZB appeared to improve clinical outcomes and reduce hospitalization duration compared to a historical control group, more rigorous testing in a randomized, placebo-controlled trial is necessary to confirm its effectiveness.
